Insider Sale by STUELPNAGEL JOHN R (Dir)
Trade Summary
1 week ago, STUELPNAGEL JOHN R, serving as Dir at 10x Genomics, Inc. (TXG), sold 20,000 shares at $61.75 per share, for a total transaction value of $1,235,071.62. Following this transaction, STUELPNAGEL JOHN R now holds 328,436 shares of TXG.
This sale represents a 5.74% decrease in STUELPNAGEL JOHN R's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Thursday, September 3, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 8, 2026 at 7:00 PM ET, 5 days after the trade was made.
10x Genomics, Inc. operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$61.75
Quantity
20,000
Total Value
$1,235,071.62
Shares Owned
328,436
Trade Date
7 days ago
SEC Filing Date
at 7:00 PM ET
Filed 5 days after trade
Discussion